Cargando…
HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK Pathway
Gastric cancer (GC) remains a health issue due to the low efficiency of therapies, such as cisplatin. This unsatisfactory situation highlights the necessity of finding factors impacting GC sensibility to therapies. We analyzed the cisplatin pangenomic response in cancer cells and found HDAC4 as a ma...
Autores principales: | Spaety, Marie-Elodie, Gries, Alexandre, Badie, Amandine, Venkatasamy, Aina, Romain, Benoit, Orvain, Christophe, Yanagihara, Kazuyoshi, Okamoto, Koji, Jung, Alain C., Mellitzer, Georg, Pfeffer, Sébastien, Gaiddon, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896094/ https://www.ncbi.nlm.nih.gov/pubmed/31703394 http://dx.doi.org/10.3390/cancers11111747 |
Ejemplares similares
-
Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
por: Badie, Amandine, et al.
Publicado: (2022) -
Ultrasound and Transcriptomics Identify a Differential Impact of Cisplatin and Histone Deacetylation on Tumor Structure and Microenvironment in a Patient-Derived In Vivo Model of Gastric Cancer
por: Venkatasamy, Aina, et al.
Publicado: (2021) -
A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatin
por: Licona, Cynthia, et al.
Publicado: (2016) -
Bypassing the Resistance Mechanisms of the Tumor Ecosystem by Targeting the Endoplasmic Reticulum Stress Pathway Using Ruthenium- and Osmium-Based Organometallic Compounds: An Exciting Long-Term Collaboration with Dr. Michel Pfeffer
por: Gaiddon, Christian, et al.
Publicado: (2021) -
Current Clinical and Pre-Clinical Imaging Approaches to Study the Cancer-Associated Immune System
por: Mueller, Christopher G., et al.
Publicado: (2021)